We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
-3.54%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$20.7B
AUM Growth
+$696M
Cap. Flow
+$853M
Cap. Flow %
4.12%
Top 10 Hldgs %
37.98%
Holding
357
New
50
Increased
42
Reduced
43
Closed
37

Top Buys

Rank Stock Value
1
ZNGA
ZYNGA INC. CL A COMMON
ZNGA
+$391M
2
TRU icon
TransUnion
TRU
+$345M
3
CERN
Cerner Corp
CERN
+$309M
4
XYZ
Block Inc
XYZ
+$266M
5
ATVI
Activision Blizzard
ATVI
+$261M

Top Sells

Rank Stock Value
1
XLNX
Xilinx Inc
XLNX
+$561M
2
BBL
BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares)
BBL
+$406M
3
RTX icon
RTX Corp
RTX
+$227M
4
CHTR icon
Charter Communications
CHTR
+$206M
5
NUAN
Nuance Communications, Inc.
NUAN
+$190M

Sector Composition

Rank Sector Weight
1 Healthcare 28.91%
2 Technology 15.84%
3 Financials 13.74%
4 Industrials 11.77%
5 Communication Services 8.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
V icon
26
Visa
V
$677B
$286M 1.38%
1,291,853
-122,751
-9% -$26.5M
EFX icon
27
Equifax
EFX
$21.4B
$283M 1.37%
1,192,703
+187,520
+19% +$44.2M
NOW icon
28
ServiceNow
NOW
$129B
$274M 1.32%
2,461,750
-54,000
-2% -$6.05M
ATVI
29
DELISTED
Activision Blizzard
ATVI
$268M 1.3%
+3,350,000
New +$261M
AVGO icon
30
Broadcom
AVGO
$2.04T
$257M 1.24%
4,088,500
-721,500
-15% -$42.9M
EXEL icon
31
Exelixis
EXEL
$13.4B
$238M 1.15%
10,520,061
+1,660,904
+19% +$32.4M
AZN icon
32
AstraZeneca
AZN
$250B
$237M 1.15%
1,788,092
+835,014
+88% +$100M
ABBV icon
33
AbbVie
ABBV
$435B
$186M 0.9%
1,144,667
-463,784
-29% -$67.4M
ALNY icon
34
Alnylam Pharmaceuticals
ALNY
$29.3B
$167M 0.81%
1,023,873
-166,155
-14% -$25.3M
HZNP
35
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
– –
-1,396,217
Closed -$136M
YMM icon
36
Full Truck Alliance
YMM
$9.99B
$155M 0.75%
23,178,743
+9,171,000
+65% +$74.2M
BEAM icon
37
Beam Therapeutics
BEAM
$2.84B
$149M 0.72%
2,594,387
+329,342
+15% +$21.6M
CLVT icon
38
Clarivate
CLVT
$1.16B
$146M 0.7%
+8,713,428
New +$144M
COHR
39
DELISTED
Coherent Inc
COHR
$129M 0.62%
471,533
+41,533
+10% +$10.9M
AVTR icon
40
Avantor
AVTR
$9.19B
$129M 0.62%
3,807,112
+164,254
+5% +$5.86M
LU icon
41
Lufax Holding
LU
$1.3B
$123M 0.59%
5,508,600
+753,750
+16% +$16.6M
CVS icon
42
CVS Health
CVS
$122B
$120M 0.58%
1,186,283
-95,173
-7% -$10M
LH icon
43
Labcorp
LH
$25.9B
$113M 0.55%
500,536
+18,443
+4% +$4.34M
ENTA icon
44
Enanta Pharmaceuticals
ENTA
$400M
$110M 0.53%
1,550,000
-23,829
-2% -$1.55M
BEKE icon
45
KE Holdings
BEKE
$18.8B
$108M 0.52%
8,713,500
+7,316,500
+524% +$130M
TSM icon
46
TSMC
TSM
$2.18T
$107M 0.52%
+1,028,125
New +$120M
IOVA icon
47
Iovance Biotherapeutics
IOVA
$2.87B
$103M 0.5%
6,175,357
+113,384
+2% +$1.75M
PLAN
48
DELISTED
Anaplan, Inc.
PLAN
$102M 0.49%
+1,570,000
New +$76.5M
NLSN
49
DELISTED
Nielsen Holdings plc
NLSN
$101M 0.49%
+3,720,000
New +$73.9M
BPMC
50
DELISTED
Blueprint Medicines
BPMC
$86.7M 0.42%
1,356,987
+545,240
+67% +$39.1M
1
2
3 4 5

Similar funds

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
ASRS
Arizona State Retirement System Phoenix, Arizona $17.1B AUM 30.52% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
VMPIC
Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Farallon Capital Management's Q1 2022 Portfolio in Review

As of Q1 2022, Farallon Capital Management held 357 positions worth $20.7B, up 3.5% from $20B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Farallon Capital Management deployed $853M of net new capital in Q1 2022, opening 50 new positions and adding to 42 existing holdings. Its largest new stake was ZYNGA INC. CL A COMMON: 44,475,000 shares worth $411M.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 32% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was RTX Corp, an estimated $227M trimmed.

  • Farallon Capital Management's largest Q1 2022 buy was ZYNGA INC. CL A COMMON: 44,475,000 shares worth $411M.
  • Farallon Capital Management added most to TransUnion in Q1 2022, an estimated $345M increase.
  • Farallon Capital Management's biggest Q1 2022 reduction was RTX Corp, cutting an estimated $227M.
  • Farallon Capital Management fully exited Xilinx Inc in Q1 2022, selling an estimated $561M.
  • Farallon Capital Management's ten largest holdings make up 38% of its $20.7B portfolio in Q1 2022.
  • Farallon Capital Management opened 50 new positions and closed 37 in Q1 2022.
  • Farallon Capital Management's portfolio value rose 3.5% quarter-over-quarter to $20.7B.

Based on Farallon Capital Management's 13F filing for Q1 2022, filed 16 May 2022.